SK284521B6 - Použitie melatonínu na prípravu farmaceutického prostriedku - Google Patents
Použitie melatonínu na prípravu farmaceutického prostriedku Download PDFInfo
- Publication number
- SK284521B6 SK284521B6 SK1030-97A SK103097A SK284521B6 SK 284521 B6 SK284521 B6 SK 284521B6 SK 103097 A SK103097 A SK 103097A SK 284521 B6 SK284521 B6 SK 284521B6
- Authority
- SK
- Slovakia
- Prior art keywords
- melatonin
- benzodiazepine
- treatment
- sleep
- patients
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/381,535 US6469044B1 (en) | 1995-02-01 | 1995-02-01 | Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies |
EP95303853A EP0724878B1 (fr) | 1995-02-01 | 1995-06-06 | Utilisation de la mélatonine pour traiter les patients souffrant d'une dépendance vis à vis d'une drogue |
PCT/IB1996/000082 WO1996023496A1 (fr) | 1995-02-01 | 1996-01-29 | Utilisation de la melatonine dans le traitement des patients souffrant d'accoutumance a certaines drogues |
Publications (2)
Publication Number | Publication Date |
---|---|
SK103097A3 SK103097A3 (en) | 1998-01-14 |
SK284521B6 true SK284521B6 (sk) | 2005-05-05 |
Family
ID=26140195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1030-97A SK284521B6 (sk) | 1995-02-01 | 1996-01-29 | Použitie melatonínu na prípravu farmaceutického prostriedku |
Country Status (22)
Country | Link |
---|---|
JP (1) | JP4516159B2 (fr) |
CN (1) | CN1083263C (fr) |
AT (1) | AT408188B (fr) |
AU (1) | AU695366B2 (fr) |
BG (1) | BG62876B1 (fr) |
BR (1) | BR9607169A (fr) |
CZ (1) | CZ291349B6 (fr) |
DK (1) | DK176081B1 (fr) |
EE (1) | EE03384B1 (fr) |
FI (1) | FI119586B (fr) |
IS (1) | IS1980B (fr) |
LU (1) | LU90118B1 (fr) |
LV (1) | LV11940B (fr) |
MD (1) | MD1716C2 (fr) |
NO (1) | NO312814B1 (fr) |
NZ (1) | NZ298878A (fr) |
PL (1) | PL183148B1 (fr) |
SI (1) | SI9620022A (fr) |
SK (1) | SK284521B6 (fr) |
TR (1) | TR199700723T1 (fr) |
TW (1) | TW483757B (fr) |
WO (1) | WO1996023496A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1272177B1 (fr) | 2000-01-05 | 2007-04-11 | Neurim Pharmaceuticals (1991) Limited | Methode et formulation permettant de traiter une resistance aux antihypertenseurs et des affections associees |
IL149377A (en) * | 2002-04-28 | 2012-10-31 | Neurim Pharma 1991 | Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds |
IL155666A (en) | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Insomnia treatment |
US9119846B2 (en) | 2003-04-29 | 2015-09-01 | Neurim Pharmaceuticals (1991) Ltd. | Method and composition for enhancing cognition in alzheimer's patients |
US11918557B2 (en) | 2012-01-26 | 2024-03-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
KR102317399B1 (ko) | 2012-01-26 | 2021-10-26 | 반다 파마슈티칼즈, 인코퍼레이티드. | 일주기 리듬 장애의 치료 |
CN105142630A (zh) | 2012-12-18 | 2015-12-09 | 万达制药公司 | 昼夜节律紊乱的治疗 |
US10376487B2 (en) | 2013-11-12 | 2019-08-13 | Vanda Pharmaceuticals Inc. | Method of treatment |
US11090285B2 (en) | 2013-11-12 | 2021-08-17 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
EP3777842A1 (fr) * | 2016-10-31 | 2021-02-17 | Neurim Pharmaceuticals Ltd. | Mini-comprimés de mélatonine et leur procédé de fabrication |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2134789T3 (es) * | 1991-05-09 | 1999-10-16 | Neurim Pharma 1991 | Composiciones que contienen melatonina. |
IT1251544B (it) * | 1991-05-13 | 1995-05-17 | Gabriele Biella | Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico |
-
1996
- 1996-01-29 WO PCT/IB1996/000082 patent/WO1996023496A1/fr active IP Right Grant
- 1996-01-29 NZ NZ298878A patent/NZ298878A/xx not_active IP Right Cessation
- 1996-01-29 SK SK1030-97A patent/SK284521B6/sk unknown
- 1996-01-29 AU AU44574/96A patent/AU695366B2/en not_active Expired
- 1996-01-29 JP JP52338596A patent/JP4516159B2/ja not_active Expired - Lifetime
- 1996-01-29 AT AT0901396A patent/AT408188B/de not_active IP Right Cessation
- 1996-01-29 SI SI9620022A patent/SI9620022A/sl not_active IP Right Cessation
- 1996-01-29 CN CN96191750A patent/CN1083263C/zh not_active Expired - Lifetime
- 1996-01-29 PL PL96321630A patent/PL183148B1/pl unknown
- 1996-01-29 MD MD97-0254A patent/MD1716C2/ro not_active IP Right Cessation
- 1996-01-29 CZ CZ19972405A patent/CZ291349B6/cs not_active IP Right Cessation
- 1996-01-29 TR TR97/00723T patent/TR199700723T1/xx unknown
- 1996-01-29 BR BR9607169A patent/BR9607169A/pt not_active Application Discontinuation
- 1996-01-29 EE EE9700166A patent/EE03384B1/xx not_active IP Right Cessation
- 1996-04-12 TW TW085104319A patent/TW483757B/zh not_active IP Right Cessation
-
1997
- 1997-07-24 LV LVP-97-144A patent/LV11940B/en unknown
- 1997-07-25 IS IS4532A patent/IS1980B/is unknown
- 1997-07-30 BG BG101803A patent/BG62876B1/bg unknown
- 1997-07-30 DK DK199700896A patent/DK176081B1/da not_active IP Right Cessation
- 1997-07-31 NO NO19973531A patent/NO312814B1/no not_active IP Right Cessation
- 1997-07-31 FI FI973185A patent/FI119586B/fi not_active IP Right Cessation
- 1997-08-01 LU LU90118A patent/LU90118B1/fr active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pallanti et al. | Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial | |
McElroy et al. | A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression | |
EP0724878B1 (fr) | Utilisation de la mélatonine pour traiter les patients souffrant d'une dépendance vis à vis d'une drogue | |
Csanalosi et al. | Gepirone in anxiety: a pilot study | |
US20100222296A1 (en) | Pyrimidines, such as uridine, in treatments for patients with bipolar disorder | |
Cardinali et al. | A double blind-placebo controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly | |
Okos et al. | Weight, lipids, glucose, and behavioral measures with ziprasidone treatment in a population with mental retardation | |
SK284521B6 (sk) | Použitie melatonínu na prípravu farmaceutického prostriedku | |
AU780817B2 (en) | Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone | |
EP2138174A1 (fr) | Composition pharmaceutique sous forme de comprimé sublingual comprenant un anti-inflammatoire non stéroïdien et un analgésique opiacé pour la gestion de la douleur | |
Neubauer | Current and new thinking in the management of comorbid insomnia | |
US20080131532A1 (en) | Fast asleep | |
CA2211839C (fr) | Utilisation de la melatonine dans le traitement des patients souffrant d'accoutumance a certaines drogues | |
US20080182904A1 (en) | Baclofen for Relapse Protection in Addiction | |
Modabbernia | Melatonin and melatonin analogues for psychiatric disorders | |
Hajak et al. | Clinical management of patients with insomnia: the role of zopiclone | |
MXPA97005856A (en) | Use of melatonine in the manufacture of unmedicament to deal with addiction to dro | |
Wurtman | Ramelteon: a melatonin receptor agonist | |
Swieca et al. | AUSTRALASIAN SLEEP ASSOCIATION POSITION STATEMENT AND GUIDELINES, REGARDING THE USE OF SODIUM OXYBATE IN THE TREATMENT OF NARCOLEPSY | |
Lee-Chiong et al. | Pharmacologic Therapy of Chronic Insomnia in Older Adults | |
Prodhan et al. | Melatonin and sleep disturbances in Alzheimer’s | |
Haino et al. | Replacement Therapy in Older Patients with Sleep Disorders | |
Joseph et al. | Insomnia: Therapy and Role of neurotransmitters |